According to the SA Health Products Authority (SAHPRA) the use of the Pfizer COVID-19 vaccine on children age 12 and above has been approved.
In a statement, the SAHPRA CEO Dr. Boitumelo Semete expressed that:
“This was as a consequence of the review of updated safety and efficacy information submitted as conditions of the Section 21 [application] initially authorised on 16 March 2021. Section 21 of the Medicines Act is a mechanism that enables emergency use access and also enables [SAHPRA] to authorise the use of a medicine, subject to certain conditions.”
Media Release – SAHPRA approval of vaccine for individuals 12 years and older pic.twitter.com/mP2sy4GL0C
— SAHPRA (@SAHPRA1) September 12, 2021
As News24 confers, “the approval comes after the launch of South Africa’s vaccine trial on children.”
Paediatric trials in South Africa are being conducted by Sinovac through Numolox (the local vaccine license holder).
More than 14 million vaccines have been administered to people thus far.
Read also:
Picture: Cape {town} Etc gallery